mortality/aging
• median lifespan of mice with leukemia is 10 months
|
hematopoietic system
• splenomegaly is obvious in males after 4 months of age
|
• males develop lymphocytosis at 3 months of age
|
• males exhibit an increase in blood B-cell number, with an expansion of the CD5+CD3-B220low IgMlow B-cell population in blood and spleens
|
• B-cell increase results from a monoclonal expansion of mature B cell-like cells
|
• 8 month old spleens of males exhibit enlarged white pulp with loss of normal splenic architecture resulting from a diffuse infiltration of mature lymphocytes
|
immune system
• splenomegaly is obvious in males after 4 months of age
|
• males develop lymphocytosis at 3 months of age
|
• males exhibit an increase in blood B-cell number, with an expansion of the CD5+CD3-B220low IgMlow B-cell population in blood and spleens
|
• B-cell increase results from a monoclonal expansion of mature B cell-like cells
|
• 8 month old spleens of males exhibit enlarged white pulp with loss of normal splenic architecture resulting from a diffuse infiltration of mature lymphocytes
|
neoplasm
• mutants, mainly males, develop a CD5+ B-cell lymphoproliferative disease by 8 months of age that resembles human chronic lymphocytic leukemia
• male mice exhibit increased splenic 18F-labeled 2-fluoro-2-deoxy-D-glucose (FDG) uptake suggesting elevated leukemic cell metabolism
|
growth/size/body
• splenomegaly is obvious in males after 4 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chronic lymphocytic leukemia | DOID:1040 |
OMIM:109543 OMIM:151400 OMIM:609630 OMIM:612557 OMIM:612558 OMIM:612559 |
J:166158 |